最終更新日：2022/12/24
The patients undergoing haploidentical HSCT were conditioned with 9.0–10.5 Gy TBI on days −7 and −6, 6 g/m 2 /day intravenous arabinosylcytosine (Ara-C) on days −5 to −3, 45 mg/kg/day intravenous CY on days −3 to −2, and 2.5 mg/kg/day intravenous anti-thymocyte globulin (ATG) (Sanofi, SangStat, Lyon, France) on days −5 to −2.
編集履歴（0）
元となった例文
The
patients
undergoing
haploidentical
HSCT
were
conditioned
with
9.0–10.5
Gy
TBI
on
days
−7
and
−6,
6
g/m
2
/day
intravenous
arabinosylcytosine
(Ara-C)
on
days
−5
to
−3,
45
mg/kg/day
intravenous
CY
on
days
−3
to
−2,
and
2.5
mg/kg/day
intravenous
anti-thymocyte
globulin
(ATG)
(Sanofi,
SangStat,
Lyon,
France)
on
days
−5
to
−2.
